A new treatment for acute myeloid leukemia could prove beneficial for even more people

by Peter MacCallum Cancer CentreAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainNew research published inScience Advancestoday conducted by researchers at Peter MacCallu

Updated on: February 20,2024

A new treatment for acute myeloid leukemia could prove beneficial for even more people

by Peter MacCallum Cancer CentreAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainNew research published inScience Advancestoday conducted by researchers at Peter MacCallu

Updated on:February 20,2024

Newly discovered mechanism helps tumor cells evade the immune system early on

byTechnical University MunichDr. Jan Böttcher, group leader and TUM Junior Fellow at the Institute of Molecular Immunology at Klinikum rechts der Isar (left) and doctoral student Sebastian Lache

Updated on: April 28,2024

Newly discovered mechanism helps tumor cells evade the immune system early on

byTechnical University MunichDr. Jan Böttcher, group leader and TUM Junior Fellow at the Institute of Molecular Immunology at Klinikum rechts der Isar (left) and doctoral student Sebastian Lache

Updated on:April 28,2024

Overcoming the limits of immunotherapies

byUniversity of WürzburgKarl Petri (left) is setting up an Emmy Noether research group at the University Hospital of Würzburg with the support of the German Research Foundation. Alexandre Truber

Updated on: August 27,2024

Overcoming the limits of immunotherapies

byUniversity of WürzburgKarl Petri (left) is setting up an Emmy Noether research group at the University Hospital of Würzburg with the support of the German Research Foundation. Alexandre Truber

Updated on:August 27,2024

Drug with immunotherapy may provide therapeutic opportunity for patients previously treated for kidney and lung cancer

by University of Texas M. D. Anderson Cancer CenterAung Naing, M.D. Credit: MD Anderson Cancer CenterPegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety r

Updated on: May 23,2024

Drug with immunotherapy may provide therapeutic opportunity for patients previously treated for kidney and lung cancer

by University of Texas M. D. Anderson Cancer CenterAung Naing, M.D. Credit: MD Anderson Cancer CenterPegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety r

Updated on:May 23,2024

State-of-the-art MRI technology bypasses need for biopsy

by UT Southwestern Medical CenterDr. Ivan Pedrosa, left, and Dr. Jeffrey Cadeddu, right, are co-authors of a study highlighted on the cover of The Journal of Urology on multiparametric MRI (mpMRI

Updated on: March 21,2024

State-of-the-art MRI technology bypasses need for biopsy

by UT Southwestern Medical CenterDr. Ivan Pedrosa, left, and Dr. Jeffrey Cadeddu, right, are co-authors of a study highlighted on the cover of The Journal of Urology on multiparametric MRI (mpMRI

Updated on:March 21,2024

Novel late-stage colorectal cancer treatment proves effective in preclinical models

by Angel Mendez,University of Minnesota Medical SchoolThe low T cells are due to exosomal, immunosuppressive miRNAs that disrupt T cell function and loss of T cells in the tumor environment. Cre

Updated on: April 29,2024

Novel late-stage colorectal cancer treatment proves effective in preclinical models

by Angel Mendez,University of Minnesota Medical SchoolThe low T cells are due to exosomal, immunosuppressive miRNAs that disrupt T cell function and loss of T cells in the tumor environment. Cre

Updated on:April 29,2024

Smoking duration, intensity tied to bladder cancer recurrence

by Lori SolomonLonger duration and more pack-years of cigarette smoking are associated with a higher risk for recurrence of non-muscle-invasive bladder cancer (NMIBC), according to a study published o

Updated on: January 10,2024

Smoking duration, intensity tied to bladder cancer recurrence

by Lori SolomonLonger duration and more pack-years of cigarette smoking are associated with a higher risk for recurrence of non-muscle-invasive bladder cancer (NMIBC), according to a study published o

Updated on:January 10,2024

Examining a potential second generation epigenetic therapy for advanced solid tumors

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainPreliminary results of a first-in-human study show manageable toxicity and preliminary antitumor activity of a potential sec

Updated on: February 18,2024

Examining a potential second generation epigenetic therapy for advanced solid tumors

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainPreliminary results of a first-in-human study show manageable toxicity and preliminary antitumor activity of a potential sec

Updated on:February 18,2024

Researchers reveal mechanism of protection against breast and ovarian cancer

by The Francis Crick InstituteCredit: Pixabay/CC0 Public DomainIn a new paper published today inNature, researchers at the Francis Crick Institute have outlined the structure and function o

Updated on: February 03,2024

Researchers reveal mechanism of protection against breast and ovarian cancer

by The Francis Crick InstituteCredit: Pixabay/CC0 Public DomainIn a new paper published today inNature, researchers at the Francis Crick Institute have outlined the structure and function o

Updated on:February 03,2024

Breast cancer spread uncovered by new molecular microscopy

byWellcome Trust Sanger InstituteConverting BaSISS spatial signals into maps of clones.a, Bar plots of cancer cell fractions (CCFs) derived from bulk WGS of the P1 samples.b, P

Updated on: January 11,2024

Breast cancer spread uncovered by new molecular microscopy

byWellcome Trust Sanger InstituteConverting BaSISS spatial signals into maps of clones.a, Bar plots of cancer cell fractions (CCFs) derived from bulk WGS of the P1 samples.b, P

Updated on:January 11,2024

Overcoming resistance to colon cancer treatment

byUniversity of GenevaColorectal cancer cells after treatment with FOLFOXIRI chemotherapy for 34 weeks. Cell fibers (in green) and nuclei (in blue). Credit: UNIGE-Nowak-SliwinskaColorectal cance

Updated on: December 28,2023

Overcoming resistance to colon cancer treatment

byUniversity of GenevaColorectal cancer cells after treatment with FOLFOXIRI chemotherapy for 34 weeks. Cell fibers (in green) and nuclei (in blue). Credit: UNIGE-Nowak-SliwinskaColorectal cance

Updated on:December 28,2023

Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-di

Updated on: August 28,2024

Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-di

Updated on:August 28,2024